BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 14747852)

  • 21. Production of horsegram (Dolichos biflorus) Bowman-Birk inhibitor by an intein mediated protein purification system.
    Kumar V; Gowda LR
    Protein Expr Purif; 2013 May; 89(1):16-24. PubMed ID: 23422783
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Study of antiproteinase activity of acylated derivatives of Bowman-Birk soybean proteinase inhibitor.
    Malykh EV; Larionova NI
    Biochemistry (Mosc); 2002 Dec; 67(12):1383-7. PubMed ID: 12600268
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Soybean bowman--birk inhibitor conjugates with clinical dextran. synthesis and antiproteolytic activity.
    Gladysheva IP; Moroz NA; Papisova AI; Larionova NI
    Biochemistry (Mosc); 2001 Apr; 66(4):384-9. PubMed ID: 11403644
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of threonine in the P2 position of Bowman-Birk proteinase inhibitors: studies on P2 variation in cyclic peptides encompassing the reactive site loop.
    McBride JD; Brauer AB; Nievo M; Leatherbarrow RJ
    J Mol Biol; 1998 Sep; 282(2):447-58. PubMed ID: 9735299
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Introduction of non-natural amino acid residues into the substrate-specific P1 position of trypsin inhibitor SFTI-1 yields potent chymotrypsin and cathepsin G inhibitors.
    Łegowska A; Debowski D; Lesner A; Wysocka M; Rolka K
    Bioorg Med Chem; 2009 May; 17(9):3302-7. PubMed ID: 19362846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies on soybean trypsin inhibitors. IV. Change of the inhibitory activity of Bowman-Birk inhibitor upon replacements of the alpha-chymotrypsin reactive site serine residue by other amino acids.
    Odani S; Ikenaka T
    J Biochem; 1978 Jul; 84(1):1-9. PubMed ID: 690093
    [No Abstract]   [Full Text] [Related]  

  • 27. The role of the P2' position of Bowman-Birk proteinase inhibitor in the inhibition of trypsin. Studies on P2' variation in cyclic peptides encompassing the reactive site loop.
    Gariani T; McBride JD; Leatherbarrow RJ
    Biochim Biophys Acta; 1999 Apr; 1431(1):232-7. PubMed ID: 10209295
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design and inhibitory properties of synthetic Bowman-Birk loops.
    Maeder DL; Sunde M; Botes DP
    Int J Pept Protein Res; 1992 Aug; 40(2):97-102. PubMed ID: 1446974
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Crystal structure of the Bowman-Birk inhibitor from barley seeds in ternary complex with porcine trypsin.
    Park EY; Kim JA; Kim HW; Kim YS; Song HK
    J Mol Biol; 2004 Oct; 343(1):173-86. PubMed ID: 15381428
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studies on soybean trypsin inhibitors. XIII. Preparation and characterization of active fragments from Bowman-Birk proteinase inhibitor.
    Odani S; Ikenaka T
    J Biochem; 1978 Mar; 83(3):747-53. PubMed ID: 25270
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies on the synthesis of proteinase inhibitors. I. Synthesis and activity of nonapeptide fragments of soybean Bowman-Birk inhibitor.
    Nishino N; Aoyagi H; Kato T; Izumiya N
    J Biochem; 1977 Sep; 82(3):901-9. PubMed ID: 914812
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 1H assignments and secondary structure determination of the soybean trypsin/chymotrypsin Bowman-Birk inhibitor.
    Werner MH; Wemmer DE
    Biochemistry; 1991 Apr; 30(14):3356-64. PubMed ID: 2012801
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Introduction of Pro and its analogues in the conserved P1' position of trypsin inhibitor SFTI-1 retains its inhibitory activity.
    Łęgowska A; Dębowski D; Łukajtis R; Sztabkowska E; Mizeria A; Brzozowski K; Wysocka M; Lesner A; Rolka K
    Protein Pept Lett; 2011 Nov; 18(11):1158-67. PubMed ID: 21605056
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isolation and characterization of soybean Bowman-Birk inhibitor from different sources.
    Gladysheva IP; Balabushevich NG; Moroz NA; Larionova NI
    Biochemistry (Mosc); 2000 Feb; 65(2):198-203. PubMed ID: 10713547
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Implication of the disulfide bridge in trypsin inhibitor SFTI-1 in its interaction with serine proteinases.
    Lęgowska A; Dębowski D; Lukajtis R; Wysocka M; Czaplewski C; Lesner A; Rolka K
    Bioorg Med Chem; 2010 Dec; 18(23):8188-93. PubMed ID: 21036622
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amino Acid Scanning at P5' within the Bowman-Birk Inhibitory Loop Reveals Specificity Trends for Diverse Serine Proteases.
    Li CY; de Veer SJ; White AM; Chen X; Harris JM; Swedberg JE; Craik DJ
    J Med Chem; 2019 Apr; 62(7):3696-3706. PubMed ID: 30888159
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of chymotrypsin inhibitors from a second-generation template assisted combinatorial peptide library.
    McBride JD; Freeman HN; Leatherbarrow RJ
    J Pept Sci; 2000 Sep; 6(9):446-52. PubMed ID: 11016881
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trypsin and chymotrypsin inhibitors from soybeans.
    Birk Y
    Methods Enzymol; 1976; 45():700-7. PubMed ID: 1034864
    [No Abstract]   [Full Text] [Related]  

  • 39. Inhibitory properties of nonapeptide loop structures related to reactive sites of soybean Bowman-Birk inhibitor.
    Terada S; Sato K; Kato T; Izumiya N
    FEBS Lett; 1978 Jun; 90(1):89-92. PubMed ID: 658446
    [No Abstract]   [Full Text] [Related]  

  • 40. Design of serine proteinase inhibitors by combinatorial chemistry using trypsin inhibitor SFTI-1 as a starting structure.
    Zabłotna E; Jaśkiewicz A; Łegowska A; Miecznikowska H; Lesner A; Rolka K
    J Pept Sci; 2007 Nov; 13(11):749-55. PubMed ID: 17828796
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.